AUB ScholarWorks

Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: Report of three cases

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search AUB ScholarWorks


My Account